The Pharmaceutical Marketing Group

The best articles from selected authors of the pharma community.

  • Home
  • Login
More

    Children’s Hospital Los Angeles Has Treated 14 Patients With Retinal Degeneration Using Gene Therapy

    LOS ANGELES--(BUSINESS WIRE)--More than a year after becoming one of the first medical institutions nationally to complete a revolutionary gene replacement surgery to restore vision in...

    Search for your favorite author

    Podcast: Trends in The New Value-Based Reimbursement Model

    Steve

    Amy

    Natalie

    Gary

    this month featured authors

    or click on the right to get a complete list of authors

    Continue to the category

    Innovative Trial Designs for Individualizing Oncology Treatments (Part 1 of 2)

    In my recent article on personalized medicine in oncology, I touched on the need for more and better clinical trials to make precision medicine...

    Virtual Trials as a Means to Increase Patient Involvement and Reduce Patient Burden

    Virtual trials, sometimes also referred to as “remote” or “site-less” trials are an innovative and emerging trial design. These trials aim to reduce the...

    10 Things I Learned About Digital Health in Brazil

    I wrote this from the perspective of the entrepreneurs I met, currently forging digital health solutions in Brazil, and where I see the opportunities...

    Five Essential Skills for Pharma’s Future Leaders

    By Steve Figman, SyntegrityThe recent eyeforpharma ‘19 conference in Philadelphia showcased an impressive array of speakers, with presentations and roundtable discussions from thought leaders...

    “Magic Mushrooms” for Psychotherapy—What Does the Evidence Say?

    What are “Magic Mushrooms”? “Magic mushrooms,” also known as “shrooms” among many other names, are mushrooms containing the hallucinogen psilocybin. This compound is found in...

    Top Tips – Building your ISO Quality Management System

    Top tips for building your ISO Quality Management System for Pharmaceutical CompaniesA Quality Management System (QMS) is key for pharma companies and should encourage...

    Importance of Patient Engagement and Empowerment for Pharma

    Except for direct participation in clinical trials and post-approval activities such as disease education, patient involvement in the biopharmaceutical development process remains episodic and...

    Connecting in the Digital Age

    Connecting in the Digital Age How Pharmaceutical Companies Can Use Marketing Outreach to Better Engage with Global Consumers By Guillem Vidal, Welocalize Life Sciences, lifesciences.welocalize.comMost companies...

    Why Too Many Clinical Trials Fail

    By Julien Moussalli Market Expansion Lead at IQVIA (LinkedIn: https://www.linkedin.com/in/julien-moussalli-80010349/)A makeover of the $65 billion clinical trials market (1) is well overdue. According to...

    Medical Marijuana and Cannabinoids for Cancer Therapy

    Medical marijuana – or cannabis – is one of the hottest topics in oncology right now. This is especially true as more and more...

    The digital game changers in pharma are not digital tools, but new aspirations

    Patient centricity, agility and digital capabilities are now the focus of many pharmaceutical companies to evolve one of the must important industries of our...

    Clinical Integration for Improving Healthcare

    As a result of rising healthcare costs, there have been widespread efforts to reform healthcare delivery worldwide. To succeed in this, many hospitals, health...

    Editor´s Pick

    184FollowersFollow
    15,000FollowersFollow
    2,506FollowersFollow

    U.S. overdose deaths post annual drop for first time in two decades

    U.S. overdose deaths dropped last year for the first time in nearly two decades, the Centers for Disease Control and Prevention said on Wednesday, in a sign that a nationwide epidemic of drug-related deaths is abating.

    Paint makers reach $305 million settlement in California, ending marathon lead poisoning lawsuit

    After a 19-year legal struggle, three former makers of lead paint have agreed to a $305 million settlement with California county and city governments to mitigate poisoning dangers still present in old housing.

    Merck’s treatment for urinary, abdominal infections gets FDA approval

    The U.S. Food and Drug Administration has approved Merck & Co Inc's combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday.

    India’s Strides tried to shred quality-control documents: FDA

    The U.S. Food and Drug Administration (FDA) has raised doubts about Strides Pharma Sciences Ltd's quality-control practices after finding adulteration and evidence of "uncontrolled shredding of documents" at one of its plants.

    Rite Aid Partners with Google Maps to Promote Safe Medication Disposal

    CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid and The Rite Aid Foundation announced today that over 550 medication disposal units across the nation are now searchable...

    Abbott to hike production of lower-cost glucose monitors as diabetes soars

    Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming to reach millions more patients worldwide, the company told Reuters.

    Democrat Harris unveils plan to lower drug costs, put ‘people over profit’

    Democratic presidential candidate Kamala Harris unveiled a plan on Tuesday to crack down on pharmaceutical companies which overcharge for prescription drugs, making her the latest 2020 White House candidate to seize on the issue.

    U.S. judge slashes Roundup jury award to $25.3 million; Bayer still plans to appeal

    A federal judge on Monday slashed a damages award Bayer AG owed a California man who blamed Roundup weed killer for his cancer, to $25.27 million from $80.27 million, while rejecting the company's bid for a new trial.

    Biden cancer group shuts down operations

    The Biden Cancer Initiative, a non-profit organization started by former Vice President Joe Biden to support cancer prevention and research, said on Monday it suspended operations last week, two and a half months after Biden and his wife resigned from the group to focus on his presidential campaign.

    GSK drug helps ovarian cancer patients live longer in late-stage study

    GlaxoSmithKline Plc's cancer treatment Zejula met the main goal of helping patients with ovarian cancer live longer without their disease worsening in a late-stage study, the company said on Monday.

    Oklahoma, J&J to wrap up first trial over opioid crisis

    Oklahoma's attorney general is expected on Monday to urge a judge to find Johnson & Johnson responsible for flooding the market with painkillers and fueling the U.S. opioid epidemic, as the first trial in nationwide litigation over the drug crisis comes to an end.

    Biden healthcare plan would curb drug prices, raise taxes on rich

    Former U.S. Vice President Joe Biden, the front-runner in the Democratic presidential race, unveiled a healthcare plan on Monday estimated to cost $750 billion and paid for partly by higher tax rates for the wealthy and doubled tax rates on capital gains.

    AstraZeneca’s Farxiga fails to get U.S. approval for Type-1 diabetes

    British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a supplement to insulin in adults with a rare-type of the condition.

    Look Who’s On the Move!

    184FollowersFollow
    15,000FollowersFollow
    2,506FollowersFollow

    Sesen Bio Announces Retirement of Leslie L. Dan

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced...

    Relay Therapeutics Names Doug Ingram and Deep Nishar to Its Board of Directors

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--#oncology--Relay Therapeutics Names Doug Ingram and Deep Nishar to Its Board of Directors...  http://www.businesswire.com/news/home/20190717005793/en/Relay-Therapeutics-Names-Doug-Ingram-Deep-Nishar

    Aurinia Announces Further Strengthening of the Senior Management Team

    VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Announces Further Strengthening of Management Team http://www.businesswire.com/news/home/20190718005139/en/Aurinia-Announces-Strengthening-Senior-Management-Team/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Gilead Sciences’ Chief Scientific Officer John McHutchison to Leave the Company

    FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that John McHutchison, AO, MD, Chief Scientific Officer and Head of Research & Development,...

    Gilead Sciences Announces Changes to Senior Leadership Team

    FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today changes to the company’s senior leadership team. Gregg Alton, Chief Patient Officer, and Katie...

    Seer Announces Appointment of Mark McClellan, MD, PhD to Board of Directors

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Seer, Inc. announces appointment of Mark McClellan, MD, PhD to Board of Directors and completion of additional $17.5 million financing...

    Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pandion Therapeutics appoints Rahul Kakkar, MD, as Chief Executive Officer. http://www.businesswire.com/news/home/20190717005190/en/Pandion-Therapeutics-Appoints-Rahul-Kakkar-MD-Chief/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Cresco Labs Hires Angie Demchenko as its First Chief People Officer

    CHICAGO--(BUSINESS WIRE)--Cresco Labs Hires Angie Demchenko as its First Chief People Officer http://www.businesswire.com/news/home/20190717005119/en/Cresco-Labs-Hires-Angie-Demchenko-Chief-People/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    Alzamend Neuro™ Announces Appointment of Dr. Eric McDade to Its Scientific Advisory Board

    TAMPA, Fla.--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/Alzamend?src=hash" target="_blank">#Alzamend</a>--Alzamend™ announces appointment of Dr. Eric McDade to its Scientific Advisory Board, Assoc. Director of Dominantly Inherited Alzheimer Ntwk (DIAN-TU)...

    Immusoft Announces the Appointment of Robert Hayes, Ph.D. as Chief Scientific Officer

    SEATTLE--(BUSINESS WIRE)--Appointment of Dr. Robert Hayes as CSO....  http://www.businesswire.com/news/home/20190717005239/en/Immusoft-Announces-Appointment-Robert-Hayes-Ph.D.-Chief/

    Research and Development

    184FollowersFollow
    15,000FollowersFollow
    2,506FollowersFollow

    Pharma Jobs Site

    Here, worldwide, recruiters will be able to post their jobs and job seekers will be able to seek them.

    Pharma Guide Website

    Your industry meeting point. Add your business for free!

    Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pandion Therapeutics appoints Rahul Kakkar, MD, as Chief Executive Officer. http://www.businesswire.com/news/home/20190717005190/en/Pandion-Therapeutics-Appoints-Rahul-Kakkar-MD-Chief/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-ANG3

    PASADENA, Calif.--(BUSINESS WIRE)--<a href="https://twitter.com/search?q=%24arwr&src=ctag" target="_blank">$arwr</a>--Arrowhead receives orphan drug designation for ARO-ANG3 for the treatment of homozygous familial hypercholesterolemia http://www.businesswire.com/news/home/20190716005964/en/Arrowhead-Pharmaceuticals-Receives-Orphan-Drug-Designation-ARO-ANG3/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and...

    SAN DIEGO--(BUSINESS WIRE)--San Diego-based Escient Pharmaceuticals announces appointment of Kristin Taylor, PhD as Vice President and Head of Clinical Development....    http://www.businesswire.com/news/home/20190717005268/en/Escient-Pharmaceuticals-Appoints-Kristin-Taylor-PhD-Vice

    Cancer Targeted Technology Commences Phase I Clinical Trial in Prostate...

    SEATTLE--(BUSINESS WIRE)--Cancer Targeted Technology commences a Phase I prostate cancer clinical trial using the radiotherapy CTT1403, and is awarded a $3.2M SBIR grant. http://www.businesswire.com/news/home/20190716005036/en/Cancer-Targeted-Technology-Commences-Phase-Clinical-Trial/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    Detailed Review of Tebentafusp (IMCgp100) in Metastatic Uveal Melanoma Published...

    OXFORD, England & CONSHOHOCKEN, Pa. & ROCKVILLE, Md--(BUSINESS WIRE)--Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announce the publication of “Tebentafusp:...

    Axial Biotherapeutics Announces First Patient Dosed in Phase 1b/2a Clinical...

    WALTHAM, Mass.--(BUSINESS WIRE)--Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced...

    AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial...

    BUNNIK, Netherlands--(BUSINESS WIRE)--AM-Pharma Raises €116m to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury....    http://www.businesswire.com/news/home/20190716005059/en/AM-Pharma-Raises-%E2%82%AC116m-133m-Conduct-Pivotal-Phase

    Alnylam and 23andMe Collaborate on +MyFamily Program to Increase Awareness...

    CAMBRIDGE, Mass. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and 23andMe, the leading consumer genetics company, are...

    Synlogic Reports Positive Top-line Data from Phase 1/2a Study of...

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--$SYBX #PKU--Synlogic reports positive top-line data from study of SYNB1618 in PKU patients....  http://www.businesswire.com/news/home/20190715005194/en/Synlogic-Reports-Positive-Top-line-Data-Phase-12a 

    AVROBIO Announces 87% Substrate Reduction in First Kidney Biopsy and...

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO announces 87% substrate reduction in 1st kidney biopsy and positive data from clinical trials of AVR-RD-01 gene therapy in Fabry disease....   http://www.businesswire.com/news/home/20190715005187/en/AVROBIO-Announces-87-Substrate-Reduction-Kidney-Biopsy/ 

    Exelixis Updates Phase 1b COSMIC-021 Trial of Cabozantinib in Combination...

    ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) today announced that two original cohorts are being expanded and four new cohorts are being added to the...

    New Immune Data from Ongoing ADXS-NEO Phase 1 Study Support...

    PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ: ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced new immune...

    Regulatory Affairs

    184FollowersFollow
    15,000FollowersFollow
    2,506FollowersFollow

    LifeMax Receives Rare Pediatric Disease Designation for LM-030 for the...

    PALO ALTO, Calif.--(BUSINESS WIRE)--LM-030 receives rare pediatric disease designation for Netherton Syndrome. Upon its approval, LifeMax may be eligible for a priority review voucher....

    FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) For the...

    KENILWORTH, N.J.--(BUSINESS WIRE)--<a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank">$MRK</a> <a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank">#MRK</a>--FDA Approves RECARBRIO™ (imipenem, cilastatin, and relebactam) For Complicated Urinary Tract and Complicated Intra-Abdominal...

    Puma Biotechnology’s Licensing Partner Knight Therapeutics Receives Regulatory Approval from...

    LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology&apos;s licensing partner Knight Therapeutics has received marketing authorization to commercialize NERLYNX in Canada. http://www.businesswire.com/news/home/20190716006021/en/Puma-Biotechnology%E2%80%99s-Licensing-Partner-Knight-Therapeutics-Receives/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    Gilead Sciences to Release Second Quarter 2019 Financial Results on...

    FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2019 financial results will be released on Tuesday, July 30,...

    Simulations Plus Enters into New Research Collaboration Agreement with the...

    LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has entered into a new 5-year Research Collaboration Agreement with the FDA's Center...

    Seattle Genetics and Astellas Announce Submission of Biologics License Application...

    BOTHELL, Wash. & TOKYO--(BUSINESS WIRE)--#bladdercancer--Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced submission...

    Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113...

    JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved...

    Dicerna Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of...

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna announced that the FDA has granted a Breakthrough Therapy Designation (BTD) to DCR-PHXC for the treatment of patients with PH1...  http://www.businesswire.com/news/home/20190715005117/en/Dicerna-Receives-Breakthrough-Therapy-Designation-DCR-PHXC-Treatment  

    Sensorion Receives FDA IND Approval for Arazasetron (SENS-401)

    MONTPELLIER, France--(BUSINESS WIRE)--Sensorion receives FDA IND Approval for Arazasetron (SENS-401)...  http://www.businesswire.com/news/home/20190711005187/en/Sensorion-Receives-FDA-IND-Approval-Arazasetron-SENS-401

    Transgene Receives MHRA Approval for Lead myvac™ Individualized Immunotherapy, TG4050,...

    STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, today announces it...

    Vivacelle Bio, Inc. Announces FDA Clearance to Enroll Patients into...

    CHICAGO--(BUSINESS WIRE)--Vivacelle Bio received FDA clearance to proceed with its trial of VBI-S, a groundbreaking therapy for shock due to sepsis...

    ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults...

    BOSTON--(BUSINESS WIRE)--ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) ....     http://www.businesswire.com/news/home/20190703005355/en/ULTOMIRIS%C2%AE-ravulizumab-Receives-Marketing-Authorization-European-Commission

    ViiV Healthcare receives EU Marketing Authorisation for Dovato (dolutegravir/lamivudine), a...

    LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the...

    Gilead Announces Intent to Submit New Drug Application for Filgotinib...

    FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced that at a recent pre-New Drug Application (NDA) meeting with the U.S. Food and...

    Alnylam Submits Marketing Authorization Application to the European Medicines Agency...

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, today announced the submission of a Marketing Authorization Application (MAA) to the European...

    Industry News

    184FollowersFollow
    15,000FollowersFollow
    2,506FollowersFollow

    Celgene Selects Lead Oncology Therapeutic Candidate Under Bispecific Antibody Collaboration...

    VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced that its global biopharma partner Celgene Corporation has...

    Convelo Therapeutics Enters Into Collaboration and Option to Acquire Agreement...

    CLEVELAND--(BUSINESS WIRE)--Convelo Therapeutics, Inc., a biotechnology company with a mission to discover a new class of medicines that regenerate the protective myelin coating around...

    Lonza Selects Rockwell Automation for Digital Transformation of Pharmaceutical Operations

    MILWAUKEE--(BUSINESS WIRE)--Lonza selects Rockwell Automation to digitally transform pharmaceutical operations. http://www.businesswire.com/news/home/20190716005078/en/Lonza-Selects-Rockwell-Automation-Digital-Transformation-Pharmaceutical/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    Cyclica and University of Toronto Stagljar Lab Announce Partnership to...

    TORONTO--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/innovation?src=hash" target="_blank">#innovation</a>--Cyclica, a Toronto-based biotechnology company leveraging AI and computational biophysics for drug discovery, and Professor Igor Stagljar from the Donnelly Centre...

    EMMAC Acquires 100% of Terra Verde

    LONDON--(BUSINESS WIRE)--EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the leading European independent medical cannabis and wellness company, is pleased to announce that it...

    AdhereHealth Selects Paxata to Accelerate Medication Adherence Solution Implementations Through...

    REDWOOD CITY, Calif.--(BUSINESS WIRE)--#dataprep--Paxata, the pioneer in self-service data preparation, today announced that AdhereHealth™, a leading healthcare technology company focused on medication adherence, has...

    Servier Australia & BioCurate Strike an Agreement to Collaborate and...

    MELBOURNE, Australia--(BUSINESS WIRE)--#BioCurate--Servier Australia and BioCurate have struck an agreement to share commercial and scientific expertise with the aim of accelerating the discovery of...

    Illumina Expands Genomics Accelerator to Cambridge, UK

    SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay...

    Paige Announces World’s First Clinical-Grade Artificial Intelligence in Pathology

    NEW YORK--(BUSINESS WIRE)--Paige, the leader in computational pathology focused on building artificial intelligence (AI) to transform the clinical diagnosis and treatment of cancer, today...

    A Fortune 500 Life Sciences Enterprise Chooses Arkivum to Provide...

    LONDON--(BUSINESS WIRE)--#longtermdata--A Fortune 500 Life Sciences enterprise chooses Arkivum to provide long term management of its GxP regulated research data....   http://www.businesswire.com/news/home/20190716005457/en/Fortune-500-Life-Sciences-Enterprise-Chooses-Arkivum 

    LifeSpan BioSciences Announces the Acquisition of Everest Biotech

    SEATTLE--(BUSINESS WIRE)--LifeSpan BioSciences (LSBio™), a leading provider of antibodies and life science research reagents, is pleased to announce its acquisition of Everest Biotech. Everest...

    Alnylam and 23andMe Collaborate on +MyFamily Program to Increase Awareness...

    CAMBRIDGE, Mass. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and 23andMe, the leading consumer genetics company, are...

    Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for...

    MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)--#ezallor--Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing...  http://www.businesswire.com/news/home/20190714005038/en/Sun-Pharma-Launches-Ezallor-Sprinkle-Rosuvastatin-U.S./

    Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology...

    INGELHEIM AM RHEIN, Germany & GENEVA--(BUSINESS WIRE)--Boehringer Ingelheim today announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company...

    Gilead and Galapagos Enter Into Transformative Research and Development Collaboration

    FOSTER CITY, Calif. & MECHELEN, Belgium--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext &amp; NASDAQ: GLPG) today announced that they have entered...

    Phone number:

    (+54911) 62650005

    Working hour:

    Mon - Frid: 09:00 - 17:00 EST

    E-mail us:

    info@pharmamkt.net